Novo Integrated Sciences, Inc. engages in the provision of medical services. The company is headquartered in Bellevue, Washington and currently employs 115 full-time employees. The company went IPO on 2005-07-12. The company operates through two reportable segments: healthcare services and product sales. Its businesses include healthcare, medical technology, manufacturing, research and diagnostics, and products and brands. Its specialized primary health care services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, and others. Its products include Terragenx and ProDip (dietary supplement pouches). Terragenx is a micro-dosing IoNovo Iodine product for all ages and lifestyles. Its medical technologies include telemedicine, and remote patient monitoring.
Novo Integrated Sciences Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Novo Integrated Sciences Inc 주요 수익원은 Healthcare Services이며, 최신 수익 발표에서 수익은 8,297,530입니다. 지역별로는 United States이 Novo Integrated Sciences Inc의 주요 시장이며, 수익은 13,294,357입니다.
Novo Integrated Sciences Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Novo Integrated Sciences Inc의 순손실은 $-16입니다.